Neurology & Immunology
We are committed to understanding the journey people living with MS face and delivering meaningful solutions that help address therapeutic needs of individual patients.
MAVENCLAD® (cladribine) tablets 10mg
- Learn more on MAVENCLAD.com
- Please click here to see full prescribing information, including the boxed warning on risk of malignancy and teratogenicity (PDF)
- Medication Guide (PDF)
Rebif® (interferon beta-1a) subcutaneous injection
leaders in Multiple Sclerosis
EMD Serono's experience and scientific discoveries in MS date back more than 20 years. We have an ongoing commitment to improving the entire patient experience. To this end, we offer delivery devices for our therapeutic products as well as comprehensive patient education resources.
It is the people living with MS or those who will be diagnosed with MS, their caregivers and healthcare providers who have been our catalyst and inspiration to continue innovating, collaborating and advocating.
Supporting the MS Community
MS LifeLines®: Comprehensive Care Resources
We know that caring for someone with MS goes beyond providing medicines, which is why we work to support people with educational programs and financial resources to address concerns about treatment and access.
For almost 20 years, MS LifeLines® has provided valuable education, information about our treatment and financial assistance programs for eligible people to address concerns about their treatment and access.
Curiosity Drives Our Future
With our history in neurology and leadership as a science-driven organization, we are deepening our commitment to people with neurological and immunological diseases by researching new therapeutic options that can make a real difference in their lives.
The development and discovery of innovative treatments for MS remains a top focus for our scientists. Our pipeline has potential to impact treatment across multiple immunological conditions, including MS, rheumatoid arthritis and systemic lupus erythematosus.
We are also investigating new treatments for immunological conditions such as psoriasis.